These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
286 related articles for article (PubMed ID: 27401736)
1. Increased plasma levels of epithelial neutrophil-activating peptide 78/CXCL5 during the remission of Neuromyelitis optica. Yang T; Wang S; Zheng Q; Wang L; Li Q; Wei M; Du Z; Fan Y BMC Neurol; 2016 Jul; 16():96. PubMed ID: 27401736 [TBL] [Abstract][Full Text] [Related]
2. Plasma osteopontin levels are associated with disease activity in the patients with multiple sclerosis and neuromyelitis optica. Shimizu Y; Ota K; Ikeguchi R; Kubo S; Kabasawa C; Uchiyama S J Neuroimmunol; 2013 Oct; 263(1-2):148-51. PubMed ID: 23910387 [TBL] [Abstract][Full Text] [Related]
3. Association of serum gamma-glutamyltransferase and C-reactive proteins with neuromyelitis optica and multiple sclerosis. Shu Y; Li R; Qiu W; Chang Y; Sun X; Fang L; Chen C; Yang Y; Lu Z; Hu X; Kermode AG Mult Scler Relat Disord; 2017 Nov; 18():65-70. PubMed ID: 29107207 [TBL] [Abstract][Full Text] [Related]
4. Increased serum level of IL-37 in patients with multiple sclerosis and neuromyelitis optica. Farrokhi M; Rezaei A; Amani-Beni A; Etemadifar M; Kouchaki E; Zahedi A Acta Neurol Belg; 2015 Dec; 115(4):609-14. PubMed ID: 26008726 [TBL] [Abstract][Full Text] [Related]
5. Increased plasma levels of pentraxin 3 in patients with multiple sclerosis and neuromyelitis optica. Wang H; Wang K; Wang C; Zhong X; Qiu W; Hu X Mult Scler; 2013 Jun; 19(7):926-31. PubMed ID: 23012252 [TBL] [Abstract][Full Text] [Related]
6. Plasma sCD28, sCTLA-4 levels in neuromyelitis optica and multiple sclerosis during relapse. Wang H; Wang K; Zhong X; Dai Y; Wu A; Li Y; Hu X J Neuroimmunol; 2012 Feb; 243(1-2):52-5. PubMed ID: 22177277 [TBL] [Abstract][Full Text] [Related]
7. Elevated plasma high-mobility group box 1 protein is a potential marker for neuromyelitis optica. Wang KC; Tsai CP; Lee CL; Chen SY; Chin LT; Chen SJ Neuroscience; 2012 Dec; 226():510-6. PubMed ID: 23122444 [TBL] [Abstract][Full Text] [Related]
8. Elevated C-X-C motif ligand 13 and B-cell-activating factor levels in neuromyelitis optica during remission. Wang S; Yang T; Wan J; Zhang Y; Fan Y Brain Behav; 2017 Apr; 7(4):e00648. PubMed ID: 28413701 [TBL] [Abstract][Full Text] [Related]
9. Distinct serum cytokine profiles in neuromyelitis optica and multiple sclerosis. Wang KC; Lee CL; Chen SY; Chen JC; Yang CW; Chen SJ; Tsai CP J Interferon Cytokine Res; 2013 Feb; 33(2):58-64. PubMed ID: 23398365 [TBL] [Abstract][Full Text] [Related]
10. Elevated fibrinogen levels in neuromyelitis optica is associated with severity of disease. Zhang Y; Zhang X; Liu D; Wang H; Pan S; Wang D; Chen X Neurol Sci; 2016 Nov; 37(11):1823-1829. PubMed ID: 27450097 [TBL] [Abstract][Full Text] [Related]
11. [Serum uric acid level and related clinical features in neuromyelitis optica]. You XF; Ye J; Qin W; Zhao WH; Hao YG; Hu WL Zhonghua Nei Ke Za Zhi; 2010 Nov; 49(11):935-8. PubMed ID: 21211206 [TBL] [Abstract][Full Text] [Related]
12. Increased plasma interleukin-32 expression in patients with neuromyelitis optica. Wang H; Wang K; Wang C; Xu F; Qiu W; Hu X J Clin Immunol; 2013 Apr; 33(3):666-70. PubMed ID: 23180362 [TBL] [Abstract][Full Text] [Related]
13. Low vitamin D-25(OH) level in Indonesian multiple sclerosis and neuromyelitis optic patients. Kusumadewi W; Imran D; Witjaksono F; Pakasi TA; Rusmana AI; Pangeran D; Marwadhani SS; Maharani K; Estiasari R Mult Scler Relat Disord; 2018 Oct; 25():329-333. PubMed ID: 30195201 [TBL] [Abstract][Full Text] [Related]
14. Serum antinuclear antibody may be associated with less severe disease activity in neuromyelitis optica. Masuda H; Mori M; Uzawa A; Muto M; Uchida T; Kuwabara S Eur J Neurol; 2016 Feb; 23(2):276-81. PubMed ID: 25903772 [TBL] [Abstract][Full Text] [Related]
15. Analyses of haptoglobin level in the cerebrospinal fluid and serum of patients with neuromyelitis optica and multiple sclerosis. Chang KH; Tseng MY; Ro LS; Lyu RK; Tai YH; Chang HS; Wu YR; Huang CC; Hsu WC; Kuo HC; Chu CC; Chen CM Clin Chim Acta; 2013 Feb; 417():26-30. PubMed ID: 23262373 [TBL] [Abstract][Full Text] [Related]
16. The possible link between elevated serum levels of epithelial cell-derived neutrophil-activating peptide-78 (ENA-78/CXCL5) and autoimmunity in autistic children. Mostafa GA; Al-Ayadhi LY Behav Brain Funct; 2015 Mar; 11():11. PubMed ID: 25871636 [TBL] [Abstract][Full Text] [Related]
17. Interferon alpha association with neuromyelitis optica. Asgari N; Voss A; Steenstrup T; Kyvik KO; Stenager E; Lillevang ST Clin Dev Immunol; 2013; 2013():713519. PubMed ID: 24348680 [TBL] [Abstract][Full Text] [Related]
18. Correlation between serum thyroxine and complements in patients with multiple sclerosis and neuromyelitis optica. Zhang B; Jiang Y; Yang Y; Peng F; Hu X Neuro Endocrinol Lett; 2008 Apr; 29(2):256-60. PubMed ID: 18404143 [TBL] [Abstract][Full Text] [Related]
19. Post-acute serum eosinophil and neutrophil-associated cytokine/chemokine profile can distinguish between patients with neuromyelitis optica and multiple sclerosis; and identifies potential pathophysiological mechanisms - a pilot study. Michael BD; Elsone L; Griffiths MJ; Faragher B; Borrow R; Solomon T; Jacob A Cytokine; 2013 Oct; 64(1):90-6. PubMed ID: 23941778 [TBL] [Abstract][Full Text] [Related]
20. Increased plasma levels epithelial cell-derived neutrophil-activating peptide 78/CXCL5 in periodontitis patients undergoing supportive therapy. Lappin DF; Murad M; Sherrabeh S; Ramage G J Clin Periodontol; 2011 Oct; 38(10):887-93. PubMed ID: 21770992 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]